Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand

详细信息    查看全文

• 作者：Tawee Chotpitayasunondh^a ; Pornpimol Pruekprasert^b ; Thanyawee Puthanakit^c ; ^d ; Chitsanu Pancharoen^c ; Auchara Tangsathapornpong^e ; Peninnah Oberdorfer^f ; Pope Kosalaraksa^g ; ^{pkosalaraksa@yahoo.com} ; Olarn Prommalikit^h ; Suwimon Tangkittithawornⁱ ; Phirangkul Kerdpanich^j ; Chonnamet Techasaensiri^k ; Joanna Korejwo^l ; Sunate Chuenkitmongkol^m ; Guy Houillon^l
• 关键词：Japanese encephalitis ; Vaccine ; JE-CV ; Safety ; Primary ; Booster
• 刊名：Vaccine
• 出版年：2017
• 出版时间：5 January 2017
• 年：2017
• 卷：35
• 期：2
• 页码：299-304
• 全文大小：348 K
• 卷排序：35

文摘

JE-CV is licensed in many countries for the prevention of Japanese encephalitis. A post-marketing study with JE-CV was performed to identify rare adverse events. No new safety risks for JE-CV were identified in a study including 10,000 children.